Bio-Bridge Science to Present at Rodman & Renshaw 11th Annual Healthcare Conference on September 11

Bio-Bridge Science, Inc. (OTCBB:BGES), a biotechnology company focused on the commercial development of biological products for the prevention and treatment of human diseases, and production materials used in producing vaccines, announced today that Dr. Liang Qiao, the Company’s chief executive officer, will present at the Rodman & Renshaw 11th Annual Healthcare Conference, on Friday, September 11, 2009, at 1:10 p.m. Eastern time in the Spellman Salon on the 5th floor of the Palace Hotel, New York City.

The presentation will give an overview of the Company, a summary of its strategic plan, as well as, discuss recent events.

This press release contains forward-looking statements. Forward-looking statements include statements concerning plans, objectives, goals, strategies, future events or performance, and underlying assumptions and other statements that are other than statements of historical facts. These statements are subject to uncertainties and risks including, but not limited to, product and service demand and acceptance, changes in technology, economic conditions, the impact of competition and pricing, government regulation, and other risks defined in this document and in statements filed from time to time with the Securities and Exchange Commission. All such forward-looking statements, whether written or oral, and whether made by or on behalf of the company, are expressly qualified by these cautionary statements and any other cautionary statements which may accompany the forward-looking statements. In addition, the company disclaims any obligation to update any forward-looking statements to reflect events or circumstances after the date hereof. Please refer to the Company's SEC filings for additional information.